Abstracts

ADMINISTRATION OF 3BNC117 AT ART INITIATION INDUCES LONG-TERM HIV CD8 T-CELL IMMUNITY

In addition to their direct antiviral effect, broadly neutralizing antibodies (bNAbs) against HIV-1 may have a vaccinal effect by stimulating T cell-specific immunity via immune complex formation leading to dendritic cell activation and enhanced antigen processing and presentation. This effect has been shown to increase the chance of post-treatment control in SHIV-infected non-human primates. To…

CD8+ LYMPHOCYTES MODULATE STEMNESS AND SURVIVAL PATHWAYS IN HIV-INFECTED CD4+ T CELLS

The persistence of HIV infection under ART is due to a reservoir of latently infected cells that harbor replication-competent virus and evade immune recognition. Defining the mechanisms responsible for the establishment and maintenance of HIV latency is crucial to achieve HIV eradication or functional cure. Previous studies demonstrated that CD8+ T-cells inhibit virus replication during…

HIGH NEUTRALIZING CONVALESCENT PLASMA RESULTS IN RAPID CLEARANCE OF SARS-CoV-2

Neutralizing antibodies are recognized as a principal correlate for protection induced by SARS-CoV-2 vaccines and have been considered for antiviral treatment as an active component in convalescent plasma therapy (CPT) and as monoclonal antibody therapeutics. However, unless used at a very early stage of infection, antibody-based SARS-CoV-2 therapies have not achieved the substantial disease-modulating effect…

PBR28 PET IMAGING IN PEOPLE WHO STARTED ART DURING ACUTE VERSUS CHRONIC HIV INFECTION

Despite antiretroviral therapy (ART), persistent immune activation is described in people-with-HIV (PWH). Using translocator protein (TSPO) PET imaging, neuroinflammation is described in PWH on ART. Early ART initiation is associated with reduced markers of inflammation. We hypothesised that neuroinflammation, measured using TSPO [11C]PBR28, would be lower in PWH who initiated ART during acute (aPWH) versus…